Dr. Philip DeFina, a world renowned Neuroscientist and well-known author, lecturer, and clinician, will be presenting his new research findings at the 64th Annual Meeting of the American Academy of Neurology (AAN). The meeting will be held in New Orleans, Louisiana, from April 21-28, 2012 at the Ernest N. Morial Convention Center. The AAN was established in 1948 and includes more than 25,000 neurologists and neuroscience professionals who want to improve neurologic care to patients.
Joining Dr. DeFina will be Dr. Max Hilz, Professor of Neurology, Director of Neurocritical Care and Vice-Chairman of the Department of Neurology at the University of Erlangen-Nuremberg, Germany. He is also Professor of Neurology, Medicine and Psychiatry at New York University School of Medicine, New York, New York.
New research entitled “Valsalva Maneuver Identifies Subtle Sympathetic Cardiac Dysfunction in Patients with Mild Traumatic Brain Injury,” will be presented by Dr. Hilz and Dr. DeFina on Wednesday, April 25, 2012 in a scientific poster section. Dr. Hilz, an IBRF Scientist and Vice Chairman, is the Principal Investigator of the study. Other members of the scientific team include Dr. Sebastian Moeller, Dr. Fabian Ammon, Dr. Joerg Markus, Dr. Steven Flanagan, and Dr. Stefan Schwab for this groundbreaking educational presentation.
An army veteran of the first Gulf War himself, Dr. DeFina and his team have been successful in awakening over fifty individuals from coma and from barely conscious or vegetative states; five of those were injured soldiers. Some have even returned to work or school. Dr. DeFina has used various treatments with success, such as electronic brain stimulation and hyperbaric oxygen therapy. He realizes the importance of the electrochemical balance in the brain. Dr. DeFina wants to reverse the thought that there is no hope for traumatic brain injury patients. Their research and worldwide collaborations focus on treatment and education in the areas of severe disorders of consciousness and coma, traumatic brain injury, Alzheimer’s and dementia, autism, learning disorders, ADHD, Parkinson’s, Cerebral Palsy and other neurological disorders.
The Advanced Care Protocol (ACP) was developed by Dr. DeFina, the Founder of the International Brain Research Foundation (IBRF), and his international team. “The ACP has a long developmental history, with years of fine tuning, utilizing a combination of brain neuromarkers to help determine the tailored novel administration of pharmaceuticals, nutritive substances, and electrical stimulation in order to jumpstart the brain of the patients. The goal of the IBRF is to continue to provide novel, cutting edge diagnostic research and clinical applications.
Dr. DeFina coordinates and facilitates groundbreaking research like the research he will be presenting at the 2012 AAN annual meeting. Dr. DeFina was a guest researcher at the National Institutes of Health, and also a member of the World Health Organization’
With funding recommended by U.S. Congressman Bill Pascrell, Jr. the U.S Department of Defense awarded IBRF a $6.4 million grant to further study the safety and efficacy of this medical protocol.
The 64th annual AAN meeting is sure to be enjoyable and educational for all in attendance. Many interesting educational topics and research in the field of neurology will be presented here. Do not miss Dr. DeFina and his colleagues as they present their newest research on “Valsalva Maneuver Identifies Subtle Sympathetic Cardiac Dysfunction in Patients with Mild Traumatic Brain Injury” on Wednesday, April 25, 2012.
For more information, visit the website at www.IBRFinc.org or contact Dr. DeFina at 732-494-7600.